HDAC9 and neoplasm: On the other hand, JNJ-10191584 is a small molecule compound categorized as the histone deacetylase (HDAC) inhibitor, which can potentially disrupt cellular epigenetic modifications to induce cell cycle arrest, apoptosis, and differentiation of tumor cells (75).